Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meixiao Long

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
International Journal of Hematologic Oncology|October 5, 2020
Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemiaBrynne Underwood, Qiuhong Zhao, Alison R Walker, et al.
Elife|February 3, 2026
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatmentYouyou Zhang, Mu Xu, Jiao Yuan, et al.
Blood Advances|August 23, 2021
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemiaEileen Y Hu, Priscilla Do, Swagata Goswami, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Cell Reports|July 20, 2022
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivityChi-Ling Chiang, Eileen Y Hu, Lingqian Chang, et al.
Cancer Cell|October 10, 2018
Integrated Analysis of Genetic Ancestry and Genomic Alterations across CancersJiao Yuan, Zhongyi Hu, Brandon A Mahal, et al.
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Blood|January 28, 2016
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemiaJoseph A Fraietta, Kyle A Beckwith, Prachi R Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyBijal Shah, Ryan J Mattison, Ramzi Abboud, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
International Journal of Hematologic Oncology|October 5, 2020
Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemiaBrynne Underwood, Qiuhong Zhao, Alison R Walker, et al.
Elife|February 3, 2026
Repression of PRMT activities sensitize human homologous recombination-proficient ovarian and breast cancer cells to PARP inhibitor treatmentYouyou Zhang, Mu Xu, Jiao Yuan, et al.
Blood Advances|August 23, 2021
The ROR1 antibody-drug conjugate huXBR1-402-G5-PNU effectively targets ROR1+ leukemiaEileen Y Hu, Priscilla Do, Swagata Goswami, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
The Journal of Clinical Investigation|July 18, 2017
Ibrutinib treatment improves T cell number and function in CLL patientsMeixiao Long, Kyle Beckwith, Priscilla Do, et al.
Cell Reports|July 20, 2022
Leukemia-initiating HSCs in chronic lymphocytic leukemia reveal clonal leukemogenesis and differential drug sensitivityChi-Ling Chiang, Eileen Y Hu, Lingqian Chang, et al.
Cancer Cell|October 10, 2018
Integrated Analysis of Genetic Ancestry and Genomic Alterations across CancersJiao Yuan, Zhongyi Hu, Brandon A Mahal, et al.
Blood Neoplasia|January 5, 2026
Safety of gemtuzumab ozogamicin with cytarabine, daunorubicin, and midostaurin induction in FLT3-mutated AMLJayanshu Jain, Kelly Pugh, Shivani Handa, et al.
Blood|January 28, 2016
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemiaJoseph A Fraietta, Kyle A Beckwith, Prachi R Patel, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyBijal Shah, Ryan J Mattison, Ramzi Abboud, et al.
Pageof 4